CYCLACEL TO HOST CONFERENCE CALL ON MONDAY, DECEMBER 7 TO DISCUSS NEW PHASE 2 SAPACITABINE DATA TO BE PRESENTED AT ASH (GLOBENEWSWIRE VIA YAHOO! FINANCE)

by Slim on December 1, 2009

BERKELEY HEIGHTS, N.J. — Cyclacel Pharmaceuticals, Inc. will horde the discussion call upon Monday, Dec 7 featuring Hagop M. Kantarjian, M.D., Chairman as well as Professor, Department of Leukemia, The University of Texas M. D.